The demand for tissue and organ transplantation is rising, particularly in high revenue generating nations. Rising incidences of diseases such as cancer, cardiovascular diseases, diabetes, Alzheimer’s disease, and renal diseases have given a rise to irreversible tissue damage over a large population worldwide. In 2019, the Centers for Disease Control and Prevention (CDC) had reported the people aging over 65 years or above have a common kidney disease and in 2018, over 726,000 were on dialysis or have transplanted their kidneys and about 125,000 people have enrolled for the end-stage kidney disease (ESKD) treatment in the U.S.
Over the forecast period (2020-2027), the global tissue and organ transplantation market is expected to witness a CAGR or 9.1% and is poised to be worth around US$ 13.9 billion in 2020.
Rising prevalence of organ failure among the global population is expected to boost growth of the global tissue and organ transplantation market.
As per the report from the WHO’s Global Observatory on Donation and Transplantation, over 119,873 organs were transplanted globally in 2014. Furthermore, rising volume of chronic diseases which are causing the failure of organs along the smoking and drinking habits across the global population will further lead to disability of organs, these factors are expected to stimulate growth of the global tissue and organ transplantation market during the forecast period. In May 2017, the Health Resources and Services Administration reported about 117,829 patients in the U.S. are waiting for organ transplantation and with 97,610 patients out of this total is waiting for kidney transplants. Although, around 11,061 transplant operations were done in between January and April 2017. Hence, skyrocketing numbers of people seeking tissue and organ transplant and the insufficient availability of organs and tissues for the transplantation has led to increase in mortality rate, these factors might create a door of opportunities in the global tissue and organ transplantation market.
- According to the End User: Hospital, Transplant Centers, Others.
- According to the type of product: Immunosuppressive Drugs, Tissue Products, and Preservation Solution.
- According to the Application: Organ Transplantation, Tissue Transplantation.
The scarcity of organs for the organ failure treatments is expected to hinder growth of the global tissue and organ transplantation market. The gap between the supply and demand of organs for treating organ failure is huge. In 2019, the U.S. Department of Health and Human Services reported that in the U.S. there are a total of 43,201 patients who need the kidney transplantation against the performed 23,401 kidney transplant operations.
Moreover, as per the World Health Resources and Services Administration, around 17 patients die every day in the U.S. seeking for an organ transplant.
Request PDF Brochure Report –
Owing to rising number of organ transplant surgeries in the U.S., the North American region is the largest market share holder in the global tissue and organ transplantation market as of 2019. In 2017, the Mayo Education and Research (MFMER) stated that around 8,000 liver transplant procedures were performed among children and adults in the U.S. Among them about 360 were from the living donors. In the same period, about 11,500 people have enrolled for liver transplant in the waiting list.
Owing to rising incidences of chronic diseases, the Asia Pacific region is expected to experience a rapid growth over the forecast period. In 2016, the global burden of disease study, had calculated the cases of cardiovascular diseases (CVDs) in India which stood at 54.5 million. 1 out of 4 deaths in India is due to CVDs along with stroke and ischemic heart disease.
Major players contributing in the global tissue and organ transplantation market are Teva Pharmaceuticals, Veloxis Pharmaceutical, CryoLife, Inc., Folio Biosciences, Stryker Corporation, BiolifeSolutions, Inc., Arthrex, Abbvie, Inc., Zimmer Biomet, Medtronic plc, and Novartis AG.
Buy This Complete A Business Report With Flat US $2000 Off @
Reasons to Purchase this Report
- Current and future of global Tissue and Organ Transplantation market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
- Regions/countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Tissue and Organ Transplantation Market Research Study are:
What will be the progress rate of the Tissue and Organ Transplantation Market for the conjecture period, 2020-2027?
What are the prominent factors driving the Tissue and Organ Transplantation Market across different regions?
Who are the major vendors dominating the Tissue and Organ Transplantation industry and what are their winning strategies?
What will be the market scope for the estimated period?
What are the major trends shaping the expansion of the industry in the coming years?
What are the challenges faced by the Tissue and Organ Transplantation Market?
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027